California Research Bond for UCSB and UC System Fails to Qualify for November Ballot Amid Federal Funding Crisis
Key Insights
A proposed $12 billion California Science and Health Research Bond Act (SB 895) missed the legislative deadline to qualify for the November 2026 ballot.
The bond aimed to counter federal research funding cuts by the Trump Administration, which has proposed approximately $32 billion in reductions to science agencies including the NSF.
UC Santa Barbara Chancellor Dennis Assanis warned that sustained federal funding losses undermine California's capacity in biomedical science, climate resilience, and public health.
A proposed $12 billion bond measure designed to shore up California's scientific and medical research enterprise has missed the deadline to qualify for the November 2026 ballot, dealing a blow to the University of California system as it grapples with unprecedented federal funding uncertainty.
Senate Bill 895, the California Science and Health Research Bond Act, was co-sponsored by the University of California and the United Auto Workers (search) (UAW), which represents UC's graduate student researchers. The measure would have given voters the opportunity to establish the California Foundation for Science and Health Research, providing long-term funding for scientists working on disease cures, wildfire prevention, and climate change mitigation.
The bill was originally designed to collect $23 billion but was reduced to $12 billion during the legislative process. While it passed the State Senate with bipartisan support, it failed to reach the Assembly floor before Thursday's deadline for measures to qualify for the November ballot.
Federal Funding Landscape Under Pressure
The bond's failure comes as the Trump Administration has slashed budgets for key science agencies, including the National Science Foundation (NSF). As of January, the administration has frozen or terminated thousands of research grants nationwide that it deemed misaligned with its priorities, with proposed budget cuts to research totaling approximately $32 billion.
"By damaging UC's research enterprise, sustained losses of federal support undermines California's ability to meet urgent statewide needs in climate resilience, wildfire and water management, biomedical science, and public health," said UCSB Chancellor Dennis Assanis in a letter to students and staff.
At UCSB, many researchers whose work is funded through federal grants — including those studying cancer (search) and climate science — face the prospect of their science simply stopping if grants are revoked. While court rulings have restored many grants that the administration initially attempted to cancel, uncertainty persists.
Proposed Changes to Grant Governance
In May, the White House Office of Management and Budget published its intent to revise Uniform Guidance, the document detailing how federal grants are administered. Proposed changes include placing funding decisions in the hands of political appointees, limiting international scientific collaboration, restricting funds for publication of results, and allowing political appointees to suspend or terminate existing grants.
"The changes they have proposed will create chaos for universities and scientists, make it very easy to cancel projects, and will replace the peer review decision process with a political appointee," said UCSB scientist David Valentine, whose research includes studies of chemical dumping off California's coastline.
Valentine further warned that the president's proposed budget seeks massive cuts to the NSF, including the Geoscience Directorate where ocean research is housed. He noted that the recent Supreme Court ruling in Trump v. Slaughter, which expanded presidential authority to fire commissioners of independent agencies, could open a pathway to further weaken science agencies.
"I am concerned that the combination of budget cuts and political control will lead to hollowed-out scientific agencies that set aside discovery based on scientific merit and instead follow political whim," Valentine said.
Economic and Scientific Return on Investment
Dr. Rachel Segalman, vice chancellor for research at UCSB, emphasized the broader economic impact of university research funding. "University research, which has been traditionally funded at the federal level, has played an important role in prolonging life, addressing critical environmental issues, and discovering breakthrough technologies that improve our standards of living," Segalman said.
She highlighted UCSB's role in the formation of the internet, iPhone technology, LED technology, and numerous medical breakthroughs, adding: "University research is estimated to return $2.50 to $3 for every dollar spent. It's a proven winning investment for Santa Barbara, Californians, and the U.S."
A Partial Reprieve: Immunotherapy Bond Qualifies
While SB 895 did not make the ballot, another $8.4 million bond measure supporting research into prevention and cures for Alzheimer's, cancer (search), and heart disease (search) did qualify. That initiative, focused on immunology and immunotherapy research, will appear on the November ballot and, if approved by voters, will backfill some of the Trump administration's cuts and freezes to California's medical research.
The research bond may have been edged out by a competing $11 billion bond to fund affordable housing supported by Governor Gavin Newsom, as too many bond measures on a single ballot can overwhelm voters and state leaders concerned with debt.
Taxpayers would have been responsible for repayment of the bonds and interest under SB 895, though potential offsets included requirements to reduce net cost to taxpayers and provisions allowing the state to recoup licensing and royalty fees from profitable inventions arising from funded research.